123 related articles for article (PubMed ID: 25156485)
1. Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors.
Li KY; Jiang J; Witte MD; Kallemeijn WW; Donker-Koopman WE; Boot RG; Aerts JM; Codée JD; van der Marel GA; Overkleeft HS
Org Biomol Chem; 2014 Oct; 12(39):7786-91. PubMed ID: 25156485
[TBL] [Abstract][Full Text] [Related]
2. Comparing Cyclophellitol N-Alkyl and N-Acyl Cyclophellitol Aziridines as Activity-Based Glycosidase Probes.
Jiang J; Beenakker TJ; Kallemeijn WW; van der Marel GA; van den Elst H; Codée JD; Aerts JM; Overkleeft HS
Chemistry; 2015 Jul; 21(30):10861-9. PubMed ID: 26073749
[TBL] [Abstract][Full Text] [Related]
3. Xylose-Configured Cyclophellitols as Selective Inhibitors for Glucocerebrosidase.
Su Q; Schröder SP; Lelieveld LT; Ferraz MJ; Verhoek M; Boot RG; Overkleeft HS; Aerts JMFG; Artola M; Kuo CL
Chembiochem; 2021 Nov; 22(21):3090-3098. PubMed ID: 34459538
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for cyclophellitol inhibition of a beta-glucosidase.
Gloster TM; Madsen R; Davies GJ
Org Biomol Chem; 2007 Feb; 5(3):444-6. PubMed ID: 17252125
[TBL] [Abstract][Full Text] [Related]
5. A sensitive gel-based method combining distinct cyclophellitol-based probes for the identification of acid/base residues in human retaining β-glucosidases.
Kallemeijn WW; Witte MD; Voorn-Brouwer TM; Walvoort MT; Li KY; Codée JD; van der Marel GA; Boot RG; Overkleeft HS; Aerts JM
J Biol Chem; 2014 Dec; 289(51):35351-62. PubMed ID: 25344605
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of hydroxymethylaminocyclitols as glycosidase inhibitors.
Trapero A; Egido-Gabás M; Bujons J; Llebaria A
J Org Chem; 2015 Apr; 80(7):3512-29. PubMed ID: 25750987
[TBL] [Abstract][Full Text] [Related]
7. A short synthesis of (+)-cyclophellitol.
Hansen FG; Bundgaard E; Madsen R
J Org Chem; 2005 Nov; 70(24):10139-42. PubMed ID: 16292857
[TBL] [Abstract][Full Text] [Related]
8. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
[TBL] [Abstract][Full Text] [Related]
9. Novel activity-based probes for broad-spectrum profiling of retaining β-exoglucosidases in situ and in vivo.
Kallemeijn WW; Li KY; Witte MD; Marques AR; Aten J; Scheij S; Jiang J; Willems LI; Voorn-Brouwer TM; van Roomen CP; Ottenhoff R; Boot RG; van den Elst H; Walvoort MT; Florea BI; Codée JD; van der Marel GA; Aerts JM; Overkleeft HS
Angew Chem Int Ed Engl; 2012 Dec; 51(50):12529-33. PubMed ID: 23139194
[TBL] [Abstract][Full Text] [Related]
10. Biological activities of cyclophellitol.
Atsumi S; Iinuma H; Nosaka C; Umezawa K
J Antibiot (Tokyo); 1990 Dec; 43(12):1579-85. PubMed ID: 2148935
[TBL] [Abstract][Full Text] [Related]
11. Carba-cyclophellitols Are Neutral Retaining-Glucosidase Inhibitors.
Beenakker TJM; Wander DPA; Offen WA; Artola M; Raich L; Ferraz MJ; Li KY; Houben JHPM; van Rijssel ER; Hansen T; van der Marel GA; Codée JDC; Aerts JMFG; Rovira C; Davies GJ; Overkleeft HS
J Am Chem Soc; 2017 May; 139(19):6534-6537. PubMed ID: 28463498
[TBL] [Abstract][Full Text] [Related]
12. Chemoenzymatic synthesis of 6-phospho-cyclophellitol as a novel probe of 6-phospho-β-glucosidases.
Kwan DH; Jin Y; Jiang J; Chen HM; Kötzler MP; Overkleeft HS; Davies GJ; Withers SG
FEBS Lett; 2016 Feb; 590(4):461-8. PubMed ID: 26790390
[TBL] [Abstract][Full Text] [Related]
13. Cyclophellitol: a naturally occurring mechanism-based inactivator of beta-glucosidases.
Withers SG; Umezawa K
Biochem Biophys Res Commun; 1991 May; 177(1):532-7. PubMed ID: 1904221
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental metastasis by an alpha-glucosidase inhibitor, 1,6-epi-cyclophellitol.
Atsumi S; Nosaka C; Ochi Y; Iinuma H; Umezawa K
Cancer Res; 1993 Oct; 53(20):4896-9. PubMed ID: 8402678
[TBL] [Abstract][Full Text] [Related]
15. Kinetic studies on cyclophellitol analogues--mechanism-based inactivators.
Tai VW; Fung PH; Wong YS; Shing TK
Biochem Biophys Res Commun; 1995 Aug; 213(1):175-80. PubMed ID: 7639733
[TBL] [Abstract][Full Text] [Related]
16. Conformational and Electronic Variations in 1,2- and 1,5a-Cyclophellitols and their Impact on Retaining α-Glucosidase Inhibition.
Ofman TP; Heming JJA; Nin-Hill A; Küllmer F; Moran E; Bennett M; Steneker R; Klein AM; Ruijgrok G; Kok K; Armstrong ZWB; Aerts JMFG; van der Marel GA; Rovira C; Davies GJ; Artola M; Codée JDC; Overkleeft HS
Chemistry; 2024 Jun; 30(31):e202400723. PubMed ID: 38623783
[TBL] [Abstract][Full Text] [Related]
17. Production, isolation and structure determination of a novel beta-glucosidase inhibitor, cyclophellitol, from Phellinus sp.
Atsumi S; Umezawa K; Iinuma H; Naganawa H; Nakamura H; Iitaka Y; Takeuchi T
J Antibiot (Tokyo); 1990 Jan; 43(1):49-53. PubMed ID: 2106502
[TBL] [Abstract][Full Text] [Related]
18. Activity-Based Probes for Glycosidases: Profiling and Other Applications.
Kuo CL; van Meel E; Kytidou K; Kallemeijn WW; Witte M; Overkleeft HS; Artola ME; Aerts JM
Methods Enzymol; 2018; 598():217-235. PubMed ID: 29306436
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of broad-specificity activity-based probes for
McGregor NGS; Kuo CL; Beenakker TJM; Wong CS; Offen WA; Armstrong Z; Florea BI; Codée JDC; Overkleeft HS; Aerts JMFG; Davies GJ
Org Biomol Chem; 2022 Jan; 20(4):877-886. PubMed ID: 35015006
[No Abstract] [Full Text] [Related]
20. Enantiospecific synthesis and biological evaluation of 1,6-epi-cyclophellitol.
Tatsuta K; Niwata Y; Umezawa K; Toshima K; Nakata M
J Antibiot (Tokyo); 1991 Apr; 44(4):456-8. PubMed ID: 1903378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
